Citigroup’s ImmuCell ICCC Stock Holding History

Citigroup’s Portfolio ICCC Stock Details ICCC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-170	Closed	-$1.1K	–	6235
2025 Q3	$1.1K	Buy	+170	New	+$1.07K	﹤0.01%	5613
2020 Q4	–	Sell	-930	Closed	-$5K	–	7473
2020 Q3	$5K	Hold	930	–	–	﹤0.01%	7019
2020 Q2	$4K	Hold	930	–	–	﹤0.01%	7313
2020 Q1	$4K	Hold	930	–	–	﹤0.01%	7315
2019 Q4	$5K	Hold	930	–	–	﹤0.01%	7391
2019 Q3	$5K	Hold	930	–	–	﹤0.01%	7330
2019 Q2	$6K	Hold	930	–	–	﹤0.01%	7438
2019 Q1	$6K	Hold	930	–	–	﹤0.01%	7378
2018 Q4	$6K	Hold	930	–	–	﹤0.01%	7303
2018 Q3	$8K	Buy	+930	New	+$6.69K	﹤0.01%	7407

Other funds holding ICCC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CAM

Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Steadtrust Allen, Texas $198M AUM 99.37% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

DIG

Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Citigroup's ICCC Position: Q4 2025 in Review

Citigroup sold out of ImmuCell (ICCC) in Q4 2025, closing a stake of 170 shares — an estimated $1.1K sold.

Citigroup first reported a position in ICCC in Q3 2018 and held it in 10 quarters. The position peaked at $8K in Q3 2018. 26 funds tracked by Wall St. Rank hold ICCC as of Q4 2025.

Citigroup reported no remaining ImmuCell position as of Q4 2025 after selling out during the quarter.
Citigroup sold 170 ImmuCell shares in Q4 2025, an estimated $1.1K.
Citigroup first reported a position in ImmuCell in Q3 2018 and held it in 10 quarters.
Citigroup's ImmuCell position peaked at $8K in Q3 2018.
26 funds tracked by Wall St. Rank held ImmuCell as of Q4 2025.

Based on Citigroup's 13F filing for Q4 2025, filed 13 Feb 2026.